Description of the Business and Financial Condition (Details) - USD ($)			3 Months Ended	18 Months Ended
	Jan. 04, 2022	Feb. 09, 2021	Mar. 31, 2022	Sep. 30, 2023	Dec. 31, 2021	Feb. 10, 2021
Subsidiary, Sale of Stock [Line Items]
Share price (in dollars per share)		$ 16.00
Convertible notes payable			$ 0			$ 0
Common stock, shares authorized (in shares)		300,000,000	300,000,000		300,000,000
Preferred stock, shares authorized (in shares)		10,000,000
Common stock, par value (in dollars per share)		$ 0.01	$ 0.01		$ 0.01
Restructuring charges	$ 3,200,000
Payments for restructuring			$ 1,100,000
Preferred stock, par value (in dollars per share)		$ 0.01
Cash and cash equivalents			73,002,000		$ 88,756,000
Accumulated deficit			229,375,000		$ 215,135,000
Accrued Liabilities
Subsidiary, Sale of Stock [Line Items]
Restructuring charges			1,900,000
Other Noncurrent Liabilities
Subsidiary, Sale of Stock [Line Items]
Restructuring charges			200,000
Forecast
Subsidiary, Sale of Stock [Line Items]
Payments for restructuring				$ 2,100,000
Research and development
Subsidiary, Sale of Stock [Line Items]
Restructuring charges			2,700,000
General and administrative
Subsidiary, Sale of Stock [Line Items]
Restructuring charges			$ 500,000
Convertible Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Convertible preferred stocks outstanding (in shares)						0
IPO and Private Placement
Subsidiary, Sale of Stock [Line Items]
Net proceeds from issuance of common stock upon initial public offering and Concurrent Private Placement, net of discount and commissions		$ 107,000,000
IPO
Subsidiary, Sale of Stock [Line Items]
Shares sold in offering (in shares)		5,750,000
Private placement
Subsidiary, Sale of Stock [Line Items]
Shares sold in offering (in shares)		1,562,500
Net proceeds from issuance of common stock upon initial public offering and Concurrent Private Placement, net of discount and commissions		$ 25,000,000
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Shares sold in offering (in shares)		750,000